After court order, Elmhurst Hospital says it’s allowing COVID-19 patient to receive controversial drug ivermectin

Chicago Tribune ^ | 05/04/2021 | John Keilman, Chicago Tribune

[SeekAndFind]

An attorney for Elmhurst Hospital said at a court hearing Tuesday that a patient whose daughter sued to procure a controversial treatment for COVID-19 has begun to receive the medication.

The lawyer, Joseph Monahan, said an outside doctor was granted credentials to work at the hospital so he could administer ivermectin to Nurije Fype, a 68-year-old who has been in intensive care for nearly a month and is on a ventilator. She received her first dose Monday night, according to Ralph Lorigo, one of her attorneys.

Monahan said the hospital’s own doctors did not want to administer the medication, which is normally used to treat patients suffering from diseases caused by parasitic worms. The Food and Drug Administration has cautioned against its use in COVID-19 cases, saying its safety and efficacy for that application has not been established.

But some researchers and physicians say they have seen good results from the drug, and when Fype’s daughter Desareta read a news story about an upstate New York woman who recovered from COVID-19 after receiving ivermectin, she went to court to secure its use for her mother.

DuPage County Judge James Orel ordered Elmhurst Hospital not to stand in the way of Fype receiving the medication. When Fype’s own doctor was unable to administer it, Lorigo said, the legal team found another physician who had to travel “1½, 2 hours each way” but was willing to do it.

Lorigo asked the judge to order Elmhurst Hospital to pay that doctor’s fees, along with Fype’s legal expenses and a $25,000 fine, and to allow a nurse to administer the drug instead of the doctor. Orel declined, saying the hospital had met the conditions of his order.

“The medication is being given,” he said.

[Pollard]

The Food and Drug Administration has cautioned against its use in COVID-19 cases, saying its safety and efficacy for that application has not been established.

Here's the trial schedule for the Pfizer jab, latter part of Phase 1 and evidently Phase 2 & 3 being run concurrently.

Four years total and it was just started last year. https://media.tghn.org/medialibrary/2020/11/C4591001_Clinical_Protocol_Nov2020_Pfizer_BioNTech.pdf

A nation of guinea pigs

[Tunehead54]

Bump to home pc.